Trials / Unknown
UnknownNCT06313255
A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this retrospective observational study is to find out the effects of probiotics on HBV clearance. The main question it aims to answer is: Are the probiotics have an effect in promoting HBV clearance? The participants will observe the HBV clearance rate in chronic hepatitis B patients receive probiotics in addition to the routine antiviral therapy. Researchers will compare the HBV clearance rate in chronic hepatitis B patients receive probiotics and antiviral therapy with those receiving solely antiviral therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PegIFNα2b | The patients receive PegIFNα2b therapy |
| DRUG | PegIFNα2b+probiotics | The patients receive both PegIFNα2b and probiotics therapy |
| DRUG | Nucleoside analog | The patients receive nucleoside analog therapy |
| DRUG | Nucleoside analog+probiotics | The patients receive both nucleoside analog and probiotics therapy |
Timeline
- Start date
- 2023-05-09
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-03-15
- Last updated
- 2024-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06313255. Inclusion in this directory is not an endorsement.